Exact Mass: 347.1521

Exact Mass Matches: 347.1521

Found 29 metabolites which its exact mass value is equals to given mass value 347.1521, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Methyl 4-(2-benzylbenzoyl)-2,5-dimethyl-1H-pyrrole-3-carboxylate

Methyl-2,5-dimethyl-4-(2-(phenylmethyl)benzoyl)-1H-pyrrole-3-carboxylic acid

C22H21NO3 (347.1521)


D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid

3-(4-{[(3-phenoxyphenyl)methyl]amino}phenyl)propanoic acid

C22H21NO3 (347.1521)


GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities[1][2][3][4].

   

Ancistrocongine

Ancistrocongine

C22H21NO3 (347.1521)


   
   

GW9508

3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid

C22H21NO3 (347.1521)


GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities[1][2][3][4].

   

waltherione C

waltherione C

C22H21NO3 (347.1521)


   
   
   
   
   
   
   
   
   
   
   

GW 9508

4-[[(3-phenoxyphenyl)methyl]amino]-benzenepropanoic acid

C22H21NO3 (347.1521)


GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities[1][2][3][4].

   

(R)-(+)-N,N-DIMETHYL-1-(1-NAPHTHYL)ETHYLAMINE

(R)-(+)-N,N-DIMETHYL-1-(1-NAPHTHYL)ETHYLAMINE

C22H21NO3 (347.1521)


   
   
   
   
   
   
   

FPL64176

Methyl-2,5-dimethyl-4-(2-(phenylmethyl)benzoyl)-1H-pyrrole-3-carboxylate

C22H21NO3 (347.1521)


D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators

   

(23r)-13-methoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

(23r)-13-methoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

C22H21NO3 (347.1521)


   

13-methoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

13-methoxy-5,7-dioxa-19-azahexacyclo[15.7.0.0²,¹⁰.0⁴,⁸.0¹¹,¹⁶.0¹⁹,²³]tetracosa-1(17),2(10),3,8,11(16),12,14-heptaene

C22H21NO3 (347.1521)


   

4-benzyl-5-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrrol-2-one

4-benzyl-5-hydroxy-3-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}pyrrol-2-one

C22H21NO3 (347.1521)


   

5-(4-methoxy-2-methylnaphthalen-1-yl)-3-methyl-1,2-dihydroisoquinoline-6,8-diol

5-(4-methoxy-2-methylnaphthalen-1-yl)-3-methyl-1,2-dihydroisoquinoline-6,8-diol

C22H21NO3 (347.1521)